SARATIN FOR INHIBITING PLATELET ADHESION TO COLLAGEN

摘要

USE OF THE POLYPEPTIDE SARATIN FOR THE MANUFACTURE OF A MEDICAMENT HAVING THE CAPABILITY TO SIGNIFICANTLY DECREASE PLATELET ADHESION AND PLATELET ACCUMULATION AFTER VASCULAR INJURIES OR ENDARTERECTOMY. THE INVENTION FURTHERMORE RELATES TO A NOVEL MEDICAL USE OF SARATIN AS AN INHIBITOR OF THROMBOSIS AND INTIMAL HYPERPLASIA, WHEREIN SAID POLYPEPTIDE MAY BE USED LOCALLY AS A TOPICAL AGENT OR AS A COATING ON, OR OTHERWISE INCORPORATED OR ASSOCIATED WITH MEDICAL DEVICES.(FIG 1)